ACTINIUM PHARMACEUTICALS, INC. Investment Income, Net
ACTINIUM PHARMACEUTICALS, INC. (ATNM) reported Investment Income, Net of $49.18 thousand for the 3-month period ending 2018-09-30, per its 10-Q filed 2018-11-09.
Discontinued › Income Statement › Other Income
us-gaap:InvestmentIncomeNet · last filed 2018-11-09
- ACTINIUM PHARMACEUTICALS, INC. investment income, net for the quarter ending 2018-09-30 was $49.18K, a 100261.22% increase year-over-year.
- ACTINIUM PHARMACEUTICALS, INC. investment income, net for the quarter ending 2018-06-30 was $50.03K.
- ACTINIUM PHARMACEUTICALS, INC. investment income, net for the quarter ending 2018-03-31 was $30.34K.
- ACTINIUM PHARMACEUTICALS, INC. investment income, net for the quarter ending 2017-12-31 was $5.38K.
- ACTINIUM PHARMACEUTICALS, INC. investment income, net for fiscal 2017 was $5.43K.
- ACTINIUM PHARMACEUTICALS, INC. investment income, net for fiscal 2016 was -$5.01K.
- ACTINIUM PHARMACEUTICALS, INC. investment income, net for fiscal 2015 was -$7.87K.
| Period end | Investment Income, Net 3 month | Investment Income, Net 6 month | Investment Income, Net 9 month | Investment Income, Net 12 month |
|---|---|---|---|---|
| 2018-09-30 | $49.18K 10-Q · filed 2018-11-09 | $99.21K derived: sum of 2 quarters · filed 2018-11-09 | $129.55K 10-Q · filed 2018-11-09 | $134.93K derived: sum of 4 quarters · filed 2018-11-09 |
| 2018-06-30 | $50.03K 10-Q · filed 2018-08-09 | $80.37K 10-Q · filed 2018-08-09 | $85.75K derived: sum of 3 quarters · filed 2018-08-09 | $85.80K derived: sum of 4 quarters · filed 2018-11-09 |
| 2018-03-31 | $30.34K 10-Q · filed 2018-05-10 | $35.72K derived: sum of 2 quarters · filed 2018-05-10 | $35.77K derived: sum of 3 quarters · filed 2018-11-09 | |
| 2017-12-31 | $5.38K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | $5.43K derived: sum of 2 quarters · filed 2018-11-09 | $5.43K 10-K · filed 2018-03-16 | |
| 2017-09-30 | $49.00 10-Q · filed 2018-11-09 | $49.00 10-Q · filed 2018-11-09 | ||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | -$666.00 derived: sum of 2 quarters · filed 2018-03-16 | -$5.01K 10-K · filed 2018-03-16 | |
| 2016-09-30 | -$666.00 10-Q · filed 2017-11-03 | -$5.01K 10-Q · filed 2017-11-03 | ||
| 2015-12-31 | -$7.87K 10-K · filed 2018-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |